Central program to advance precision care for kidney disease
Central Hub for Kidney Precision Medicine
This project coordinates how researchers collect and share high-quality kidney tissue and patient data to help people with kidney injury and other kidney diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11173799 on NIH RePORTER |
What this research studies
As a patient, I would see the Central Hub as the team that organizes how kidney tissue and clinical information are collected, stored, and shared with researchers. They make sure samples and data meet strict quality and safety standards, coordinate recruitment clinics and labs that analyze tissues, and keep patients informed and respected. The Hub supports a Kidney Tissue Atlas so data are Findable, Accessible, Interoperable, and Reusable for future research. By linking recruitment sites, tissue analysis groups, and an Opportunity Pool for new collaborations, it aims to speed discoveries that could benefit people like me.
Who could benefit from this research
Good fit: Ideal candidates are people with acute kidney injury or other kidney diseases who are willing to provide clinical information and, when appropriate, tissue samples or participate in follow-up visits.
Not a fit: People without kidney disease or those who cannot or do not want to provide clinical data or tissue samples may not directly benefit from participating.
Why it matters
Potential benefit: If successful, this could speed development of more precise diagnoses and treatments for people with kidney injury by making high-quality tissue and data widely available to researchers.
How similar studies have performed: This builds on the first phase of the Kidney Precision Medicine Project (KPMP), which established infrastructure and initial tissue atlases, so the approach has prior supporting work rather than being entirely untested.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Himmelfarb, Jonathan — Icahn School of Medicine at Mount Sinai
- Study coordinator: Himmelfarb, Jonathan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.